Salvage cryoablation shows clinical benefit in delaying hormone therapy for men with locally recurrent prostate cancer

05:30 EDT 21 May 2018 | ecancermedicalscience

Androgen deprivation therapy (ADT) is commonly administered to many men whose prostate cancer returns after initial radiation treatment. But this hormone therapy comes with the risk of side effects – from cardiac damage to hot flashes to psychological...

More From BioPortfolio on "Salvage cryoablation shows clinical benefit in delaying hormone therapy for men with locally recurrent prostate cancer"